Legal Representation
Attorney
Franco A. Serafini
USPTO Deadlines 2 active
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
MAINTENANCE
Section 8 (6-Year) Declaration Due (Based on registration date 2025-06-03) |
R.PRA | Jun 03, 2031 | 2157 days | Critical | No |
|
MAINTENANCE
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2025-06-03) |
R.PRA | Jun 03, 2035 | 3618 days | Critical | No |
Next deadline: Section 8 (6-Year) Declaration Due (Based on registration date 2025-06-03)
on June 03, 2031
(2157 days)
Application History
19 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 3, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Jun 3, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Apr 15, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Apr 15, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Apr 9, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Mar 11, 2025 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Feb 22, 2025 | RFNT | P | REFUSAL PROCESSED BY IB |
| Feb 21, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Feb 21, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 21, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 21, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jan 31, 2025 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Jan 31, 2025 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Dec 28, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Dec 27, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Dec 23, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Nov 15, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Nov 15, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Nov 14, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 005
Pharmaceutical, biopharmaceutical, and veterinary preparations for the treatment of cancer, particularly skin cancer, including melanoma and non-melanoma skin cancer; antibodies and antibody fragments derivatives including human monoclonal antibodies and related fragments conjugated to cytokines.
Active Deadlines
Section 8 (6-Year) Declaration Due (Based on registration date 2025-06-03)
Due: Jun 03, 2031
Grace Period Until: Dec 03, 2031
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2025-06-03)
Due: Jun 03, 2035
Grace Period Until: Dec 03, 2035
Additional Information
Design Mark
The mark consists of the green wording NIDLEGY. Above it is a partial circle in yellow, grey, blue, green, and white.
Color Claim
The color(s) green, yellow, gray, blue and white is/are claimed as a feature of the mark.
Classification
International Classes
005